Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NTX-301 |
Trade Name | |
Synonyms | NTX 301|NTX301 |
Drug Descriptions |
NTX-301 inhibits DNMT1, potentially leading to reduced tumor growth and improved survival (PMID: 35410412; J Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS7077). |
DrugClasses | DNMT1 inhibitor 4 |
CAS Registry Number | NA |
NCIT ID | C174424 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + NTX-301 | Carboplatin NTX-301 | 0 | 1 |
Cisplatin + NTX-301 | Cisplatin NTX-301 | 0 | 1 |
NTX-301 | NTX-301 | 0 | 2 |
NTX-301 + Temozolomide | NTX-301 Temozolomide | 0 | 1 |